Searched for: person:caplaa01
The year is 2000; the year is 2025
Caplan, Arthur
PMID: 23311829
ISSN: 1526-5161
CID: 213362
Expanding access to testicular tissue cryopreservation: an analysis by analogy
Ruutiainen, Tuua; Miller, Steve; Caplan, Arthur; Ginsberg, Jill P
Researchers are developing a fertility preservation technique--testicular tissue cryopreservation (TTCP)--for prepubescent boys who may become infertile as a result of their cancer treatment. Although this technique is still in development, some researchers are calling for its widespread use. They argue that if boys do not bank their tissue now, they will be unable to benefit from any therapies that might be developed in the future. There are, however, risks involved with increasing access to an investigational procedure. This article examines four methods of expanding access to TTCP: (1) expansion of institutional review board (IRB)-approved research trials; (2) offering TTCP as an innovative procedure in hospitals; (3) offering TTCP as a standard practice in hospitals; and (4) commercialization of TTCP. The ethical and practical implications of each are evaluated through a comparison with umbilical cord blood banking (UCBB), a technology that has achieved widespread use based on similar claims of future benefit.
PMID: 23428034
ISSN: 1526-5161
CID: 336152
Response to open peer commentaries on "expanding access to testicular tissue cryopreservation: an analysis by analogy"
Ruutiainen, Tuua; Miller, Steve; Caplan, Arthur; Ginsberg, Jill P
PMID: 23557063
ISSN: 1526-5161
CID: 334262
Ethics of cost containment for cancer therapies: will the Affordable Care Act bring down costs? [Interview]
Caplan, Arthur
PMID: 23413608
ISSN: 0890-9091
CID: 336162
Little hope for medical futility [Editorial]
Caplan, Arthur L
PMCID:3532674
PMID: 23127730
ISSN: 0025-6196
CID: 202172
Thomas Szasz: rebel with a questionable cause [Historical Article]
Williams, Arthur R; Caplan, Arthur L
PMID: 23091833
ISSN: 0140-6736
CID: 180752
Big Talk. No Action. Not Bad
Caplan, Arthur L
Caplan talks about New York Mayor Michael Bloomberg's decision to ban large sugary drinks. Bloomberg proposed that no business in New York City should sell soda and other sugary drinks bigger than sixteen ounces. Keeping humongous containers of Coke, Pepsi, Mountain Dew, A&W root beer, and other such calorie-infested potions off-limits might help trim the ever-expanding girth of New Yorkers. He admires the mayor for taking on gigantic portions of food and drink as a source of obesity. However, he notes that a ban on big sugary drinks both unfair and unlikely to have any impact on the obesity epidemic
PROQUEST:1095311047
ISSN: 0272-0701
CID: 1496202
Enhancing Patient Autonomy Through Peer Review To Replace The FDA's Rigorous Approval Process
Caplan, Arthur
There may once have been a time when doctors unquestioningly accepted the government's declaration of a drug's effectiveness and when patients unquestioningly accepted the prescriptions of their doctors. That time has passed. Now, information-good and bad-showers from all directions on patients and physicians alike. A filter is needed, and peer review provides the best one. But who or what is this validated information for? Ethically, its primary purpose is to enable patients to make decisions consistent with their values. Providing vetted information in a form that is useful to patients requires an emphasis on comprehensible, comprehensive, trustworthy, verifiable, and transparent communication. The hypothetical comparative effectiveness case study in this month's Health Affairs does not appear to rise to the level that would be helpful to providers or patients.
PMID: 23048103
ISSN: 0278-2715
CID: 182342
Without an adequate ethical infrastructure, the road to personalized medicine will be rocky at best
Caplan, A L
Discovering the genetic variations that create profiles of risk and drive individual responses to drugs and vaccines has proven more difficult than many initially presupposed. Rhetoric about the prospect of personalized medicine has exceeded the ability to deliver on that vision. There also remain significant ethical and policy obstacles that may hinder the arrival of personalized medicine. The emergence of new prenatal genetic tests make the resolution of these ethical challenges imperative.
PMID: 22992666
ISSN: 0009-9236
CID: 178241
Not my turn
Caplan, Arthur L
PMID: 22988581
ISSN: 0140-6736
CID: 178238